2021
Diversity Inclusion in United States Opioid Pharmacological Treatment Trials: A Systematic Review
Nalven T, Spillane N, Schick M, Weyandt L. Diversity Inclusion in United States Opioid Pharmacological Treatment Trials: A Systematic Review. Experimental And Clinical Psychopharmacology 2021, 29: 524-538. PMID: 34242040, PMCID: PMC8511246, DOI: 10.1037/pha0000510.Peer-Reviewed Original ResearchConceptsOpioid use disorderPharmacological treatmentPharmacological treatment trialsTreatment trialsRandomized controlled trialsLack of subgroup analysesDiverse sampleMultiracial individualsNative Hawaiian/Other Pacific IslanderAmerican Indian/Alaska Native (AI/ANMedication typeSystematic reviewPharmacological careMarginalized backgroundsRandomized clinical trialsPreferred Reporting ItemsBlack individualsOpioidSex/genderSES indicatorsNaltrexoneSubgroup analysisClinical trialsReporting ItemsIncreased risk
2018
Creation and validation of the barriers to alcohol reduction (BAR) scale using classical test theory and item response theory
Kunicki Z, Schick M, Spillane N, Harlow L. Creation and validation of the barriers to alcohol reduction (BAR) scale using classical test theory and item response theory. Addictive Behaviors Reports 2018, 7: 47-52. PMID: 29450256, PMCID: PMC5805497, DOI: 10.1016/j.abrep.2018.01.004.Peer-Reviewed Original ResearchItem response theoryClassical test theoryYoung Adult Alcohol Consequences QuestionnaireBrief Young Adult Alcohol Consequences QuestionnaireExploratory structural equation modelingBinge drinkingAlcohol-related consequencesTwo-factor structureNon-binge drinkersResponse theoryPast-month binge drinkingAlcohol reductionConsequences QuestionnaireStructural equation modelingTest theoryDiscriminant validityDrinking behaviorConvergent validityBinge drinkersCollege studentsDiverse sampleUndergraduate student populationInternal consistencyPhysical activityUnidimensionality assumption